Specialised Trials
Specialised Trials is an Australian pathology services subsidiary of Australian Clinical Labs providing end-to-end Phase I-V clinical trial pathology management — including testing, kit production, specimen collection across 900+ centres, logistics, storage, and HL7-based data delivery — to CROs, pharmaceutical, and biotechnology clients.
- Company typePrivate
- Founded2019
- HeadquartersPort Melbourne, Australia
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Specialised Trials does
Specialised Trials is an Australian pathology services provider dedicated to Phase I-V clinical trials, operating as a wholly-owned subsidiary of Australian Clinical Labs — one of Australia's largest private pathology operators, which runs 90 NATA-accredited laboratories processing approximately 8 million episodes annually. The company offers an end-to-end pathology management platform spanning eight interconnected service modules: extensive test offering with customisable reference ranges and analyte outsourcing, electronic request forms with instant HL7 transmission, customised kit production (assembled at Port Melbourne), participant specimen collections across 900+ Australian collection centres plus home/hospital/onsite options, nationwide temperature-monitored courier logistics with tracking, dual-location refrigerated and frozen specimen storage, customisable data extraction with secure transmission to trial aggregators, and result delivery via HL7, online portal, or local printer.
The company's target customers are clinical research organisations, pharmaceutical companies, and biotechnology firms conducting regulated trials in Australia. All staff and laboratories hold NATA and GCLP accreditation, which functions as a regulatory entry barrier. The technology layer is a digital pathology management system centred on HL7 interoperability, paperless form transfers, and a web-based portal accessible on tablet or smartphone — standard healthcare integration tooling rather than a proprietary AI or analytics platform. Distribution is exclusively domestic and executed through direct enterprise field sales backed by a website and phone enquiry channel; pricing is quote-based with no public disclosure.
The commercial model is professional services revenue from bespoke clinical trial contracts, with the unit operating on a small dedicated team of 6 employees across two sites (Port Melbourne, Victoria and Murarrie, Queensland), heavily leveraging the parent's national collection-centre network and laboratory footprint for delivery scale. No independent funding, ownership, or revenue figures are disclosed in public material.
Specialised Trials firmographics
Firmographics- Name
- Specialised Trials
- Legal name
- Specialised Trials
- Website
- https://specialisedtrials.com.au
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Specialised Trials is an Australian pathology services subsidiary of Australian Clinical Labs providing end-to-end Phase I-V clinical trial pathology management — including testing, kit production, specimen collection across 900+ centres, logistics, storage, and HL7-based data delivery — to CROs, pharmaceutical, and biotechnology clients.
- Ownership category
- akta.pro rank
Specialised Trials industry classification
Industry- Product category
- Clinical Trial Pathology Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Research & Trial Central Laboratories (HLAFAMAL)
- akta.pro secondary industries
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)
Keywords
Where Specialised Trials is headquartered
LocationHeadquarters
- HQ city
- Port Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Specialised Trials business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Trial Pathology Services: End-to-end pathology management solutions for clinical research, pharmaceutical and biotechnology clients including extensive test offerings, kit production, specimen collection, logistics, storage, and data extraction services.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Specialised Trials product offering
Product offeringCore offering
Specialised Trials provides central laboratory pathology services to support Phase I–V clinical trials conducted by pharmaceutical, biotechnology, and contract research organizations. Its offering covers the full specimen lifecycle, including test menu design, kit production, sample collection, logistics and storage, laboratory analysis, and delivery of results. The business operates as a dedicated clinical trials arm leveraging the infrastructure of its parent network.
Product overview
Specialised Trials is a subsidiary of Australian Clinical Labs offering a unified pathology management platform for Phase I-V clinical trials. The integrated service portfolio includes eight interconnected modules: Extensive Test Offering (customisable diagnostic tests with NATA/GCLP accreditation), Electronic Request Forms (HL7-enabled digital requests), Kit Production and Supplies (custom trial kits from Port Melbourne), Participant Specimen Collections (900+ collection centres plus home/hospital options), Logistics Solutions (temperature-monitored nationwide courier fleet), Specimen Storage (dual-location redundant storage), Data Extraction (secure customisable data management), and Result Delivery Options (HL7, portal, and printer delivery). Together these services provide end-to-end pathology management from initial inquiry through delivery for clinical research, pharmaceutical, and biotechnology clients.
Differentiator
Problem solved
Functional benefit
Products and services
- Test Offerings
- Kit Production
- Specimen Collections
- Logistics and Storage
- Data Extraction and Result Delivery Extraction, validation, and electronic delivery of laboratory results to sponsors, CROs, and investigator sites, formatted to support clinical trial reporting requirements.
Quantifiable outcome
- Seamless transition from initial inquiry through to delivery
- +2 more outcomes
Companies that use Specialised Trials
Customer profileSegments3 records
Ideal customer profiles2 records
Specialised Trials technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Specialised Trials partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Australian Clinical LabsflagshipSpecialised Trials is a subsidiary of Australian Clinical Labs. This parent-subsidiary relationship provides Specialised Trials with access to 90 NATA accredited laboratories performing approximately 8 million episodes annually, making it one of Australia's largest private pathology providers. Australian Clinical Labs combines pathology leadership, ground-breaking technology, and scientific expertise to deliver better outcomes for doctors and patients.
Scale indicators3 records
Expansion highlights4 records
Specialised Trials competitors and assessment
Company assessmentDirect peers
- ACM Global Laboratories: ACM Global is one of the world's largest independent central laboratories dedicated to clinical trials, offering similar end-to-end specimen management, kit production, logistics, and biomarker testing services to pharma and CROs. Directly comparable in product scope, customer segments, and central lab operating model to Specialised Trials.
- ICON plc (Central Labs): ICON Central Labs (formed from the merger with PRA Health Sciences) provides global central laboratory services for clinical trials, including kit production, specimen logistics, and bioanalytical testing. Comparable in trial central lab operating model and CRO-aligned customer base.
- Eurofins Central Laboratory: Eurofins Central Laboratory provides global central lab and specialty testing services for clinical trials, with operations across multiple continents. Competes directly with Specialised Trials in the trial central lab category, offering comparable kit production, logistics, and biomarker capabilities at global scale.
- Q² Solutions (IQVIA): Q² Solutions is a leading global clinical trial laboratory services organization formed from Quintiles and Quest Diagnostics, providing central lab, bioanalytical, and specialty testing for clinical trials. Comparable in trial-focused central lab services, biomarker testing, and global data integration, though at significantly larger scale.
- PPD Central Labs (Thermo Fisher Scientific): PPD's central laboratory (now part of Thermo Fisher Scientific's Clinical Research Services) offers global central lab, kit production, and specialty testing for clinical trials. Directly comparable to Specialised Trials in central lab services for pharma/biotech trials.
- Labcorp Central Labs (formerly Covance): Labcorp's central laboratory services (inheriting the Covance Central Labs franchise) provide global central lab testing, kit production, and data management for clinical trials. Direct competitor in trial central lab services with broader geographic footprint and assay menu.
Broad incumbents
- Medpace Holdings: Medpace is a mid-sized CRO that includes central laboratory services as part of its full-service clinical development offering. Comparable in trial-services customer base and central lab capabilities, but operates primarily in US/EU and at different scale.
- Sonic Healthcare: Sonic Healthcare is one of the largest diagnostic pathology providers in Australia and globally, operating a broad network of community pathology labs. Comparable as an Australian pathology incumbent with scale advantages, but not specialized in clinical trial central lab services like Specialised Trials.
- Healius Limited: Healius (formerly Primary Health Care Limited) operates one of Australia's largest pathology networks, including specialty divisions. Comparable as a domestic pathology incumbent with broad service portfolio, but lacks Specialised Trials' specific clinical trial central lab focus.
Regional players
- Frontier Pathology (Australian Clinical Labs): Australian Clinical Labs itself — Specialised Trials' parent — operates Frontier Pathology and other regional pathology brands across Australia. Comparable as a regional pathology services provider within Australia, though positioned differently as a general diagnostic lab rather than trial-focused central lab.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Specialised Trials social profiles
Digital presenceSpecialised Trials compliance and trust
Trust signalCompliance2 records
Specialised Trials financial estimates
Financial estimateRevenue estimate
Valuation estimate
Specialised Trials leadership team
Management profileNumber of profiles
Specialised Trials funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Specialised Trials M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Specialised Trials
What does Specialised Trials do?
Specialised Trials provides central laboratory pathology services to support Phase I–V clinical trials conducted by pharmaceutical, biotechnology, and contract research organizations. Its offering covers the full specimen lifecycle, including test menu design, kit production, sample collection, logistics and storage, laboratory analysis, and delivery of results. The business operates as a dedicated clinical trials arm leveraging the infrastructure of its parent network.
Is Specialised Trials a public or private company?
Specialised Trials is a private company. It is classified as corporate owned and is currently operating.
When was Specialised Trials founded?
Specialised Trials was founded in 2019. It employs 1 to 10 people.
Where is Specialised Trials based?
Specialised Trials is headquartered in Port Melbourne, Australia, in the Oceania region.
How does Specialised Trials make money?
One revenue line is on record: clinical Trial Pathology Services.
Who are Specialised Trials's main competitors?
Direct peers on record are ACM Global Laboratories, ICON plc (Central Labs), Eurofins Central Laboratory, Q² Solutions (IQVIA), PPD Central Labs (Thermo Fisher Scientific) and Labcorp Central Labs (formerly Covance). Broad incumbents are Medpace Holdings, Sonic Healthcare and Healius Limited. Frontier Pathology (Australian Clinical Labs) is listed as a regional player.
Does Specialised Trials have an API?
No public API is recorded for Specialised Trials.
What industry is Specialised Trials in?
Specialised Trials's product category is Clinical Trial Pathology Services. Its primary akta.pro industry code is HLAFAMAL, Clinical Research & Trial Central Laboratories, with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 621511 and its SIC code is 8071.